Featured Research

from universities, journals, and other organizations

Scorpion Sting: Antivenom Results In Prompt Recovery From Nerve Poisoning, Study Shows

Date:
May 14, 2009
Source:
University of Arizona, College of Pharmacy
Summary:
Youngsters suffering severe nerve poisoning following a scorpion sting recover completely and quickly if a scorpion-specific antivenom is administered, according to a new study.

Youngsters suffering severe nerve poisoning following a scorpion sting recover completely and quickly if a scorpion-specific antivenom is administered, according to a study conducted by researchers from The University of Arizona.

Related Articles


The study was conducted with 15 children in Tucson, Ariz., during 2004 and 2005. All of the children had been admitted to a pediatric intensive care unit following a scorpion sting and were experiencing abnormal eye movements, uncontrolled thrashing of limbs and respiratory distress, all symptoms of nerve poisoning caused by the venom of the bark scorpion.

The principal investigator of the study and lead author of the article is Leslie Boyer, MD, director of the VIPER (Venom Immunochemistry, Pharmacology and Emergency Response) Institute at The University of Arizona College of Medicine and medical director of the Arizona Poison and Drug Information Center at the UA College of Pharmacy.

In the study, eight of the children, most of whom were under 6 years, received a scorpion antivenom that is commercially available in Mexico but is considered an investigational drug in the United States and is not approved for general use by the U.S. Food and Drug Administration. The seven other study participants received a placebo (a preparation containing no medication).

The symptoms of nerve poisoning were resolved in all of the children treated with the antivenom in less than four hours, and usually within two hours. The children who received the placebo continued to experience nerve poisoning for four hours or more and required large doses of sedative medication and extended hospitalization.

"This study told us that the dangerous effects of bark scorpion venom can be reversed quickly with the right antivenom," Dr. Boyer says. "One hundred percent of the children who received it got better very quickly, meaning that using this antivenom in the emergency room will make intensive care treatment unnecessary for most patients. This is particularly important in small Arizona towns without pediatric intensive care units. By avoiding helicopter trips and intensive care stays, we can save lives and keep treatment costs down at the same time."

Andreas Theodorou, MD, a professor of pediatrics and chief medical officer of University Medical Center in Tucson, was part of the study team.

"This antivenom basically takes symptoms away in a very short time," Dr. Theodorou says. "What was a life-threatening disease that would put kids in the pediatric ICU has become, for most of them, an outpatient disease."

The study reported in The New England Journal of Medicine involved Anascorpฎ, an antivenom made and supplied to the UA at no charge by the pharmaceutical company Instituto Bioclon, headquartered in Mexico City.

The study was funded by a grant from the Office of Orphan Products Development of the FDA. Starting in 2004, additional funding from the State of Arizona has enabled 22 hospitals throughout the state to participate in the study and provide antivenom to their patients.


Story Source:

The above story is based on materials provided by University of Arizona, College of Pharmacy. Note: Materials may be edited for content and length.


Journal Reference:

  1. Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings. The New England Journal of Medicine, May 14, 2009

Cite This Page:

University of Arizona, College of Pharmacy. "Scorpion Sting: Antivenom Results In Prompt Recovery From Nerve Poisoning, Study Shows." ScienceDaily. ScienceDaily, 14 May 2009. <www.sciencedaily.com/releases/2009/05/090513173452.htm>.
University of Arizona, College of Pharmacy. (2009, May 14). Scorpion Sting: Antivenom Results In Prompt Recovery From Nerve Poisoning, Study Shows. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2009/05/090513173452.htm
University of Arizona, College of Pharmacy. "Scorpion Sting: Antivenom Results In Prompt Recovery From Nerve Poisoning, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2009/05/090513173452.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) — Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Din้ Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins